 | NMC | Name: | N-CYCLOPROPYLMETHYL GLYCINE | Formula: | C6 H11 N O2 | SMILES: | O=C(O)CNCC1CC1 | InChi: | InChI=1S/C6H11NO2/c8-6(9)4-7-3-5-1-2-5/h5,7H,1-4H2,(H,8,9) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-(cyclopropylmethyl)glycine |
|
 | ZLF | Name: | S-(1-FLUORO-3,5-DIMETHYLBENZENE)-CYSTEINE | Formula: | C11 H14 F N O2 S | SMILES: | Cc1cc(F)cc(CSC[CH](N)C(O)=O)c1 | InChi: | InChI=1S/C11H14FNO2S/c1-7-2-8(4-9(12)3-7)5-16-6-10(13)11(14)15/h2-4,10H,5-6,13H2,1H3,(H,14,15)/t10-/m0/s1 | Synonyms: | 2-azanyl-3-[(3-fluoranyl-5-methyl-phenyl)methylsulfanyl]propanoic acid | Definition date: | 2024-01-22 | Last modified: | 2024-09-27 | Release date: | 2024-04-24 | Identifier: | 2-azanyl-3-[(3-fluoranyl-5-methyl-phenyl)methylsulfanyl]propanoic acid |
|
 | RAM | Name: | alpha-L-rhamnopyranose | Formula: | C6 H12 O5 | SMILES: | OC1C(O)C(OC(O)C1O)C | InChi: | InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3-,4+,5+,6+/m0/s1 | Synonyms: | alpha-L-rhamnose | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 6-deoxy-alpha-L-mannopyranose |
|
 | QIL | Name: | N-formyl-L-isoleucine | Formula: | C7 H13 N O3 | SMILES: | O=CNC(C(=O)O)C(CC)C | InChi: | InChI=1S/C7H13NO3/c1-3-5(2)6(7(10)11)8-4-9/h4-6H,3H2,1-2H3,(H,8,9)(H,10,11)/t5-,6-/m0/s1 | Definition date: | 2011-05-25 | Last modified: | 2024-09-27 | Identifier: | N-formyl-L-isoleucine |
|
 | VQN | Name: | (phenylmethyl) ~{N}-[(2~{R})-1-[[(~{Z},2~{S})-5-[4-[[1-[2-[(3~{R})-2,6-bis(oxidanylidene)piperidin-3-yl]-6-fluoranyl-1,3-bis(oxidanylidene)isoindol-5-yl]piperidin-4-yl]methyl]piperazin-1-yl]-5-oxidanylidene-1-[(3~{R})-2-oxidanylidenepyrrolidin-3-yl]pent-3-en-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate | Formula: | C46 H57 F N8 O9 | SMILES: | CC(C)C[CH](NC(=O)OCc1ccccc1)C(=O)N[CH](C[CH]2CCNC2=O)C=CC(=O)N3CCN(CC3)CC4CCN(CC4)c5cc6C(=O)N([CH]7CCC(=O)NC7=O)C(=O)c6cc5F | InChi: | InChI=1S/C46H57FN8O9/c1-28(2)22-36(50-46(63)64-27-30-6-4-3-5-7-30)42(59)49-32(23-31-12-15-48-41(31)58)8-11-40(57)54-20-18-52(19-21-54)26-29-13-16-53(17-14-29)38-25-34-33(24-35(38)47)44(61)55(45(34)62)37-9-10-39(56)51-43(37)60/h3-8,11,24-25,28-29,31-32,36-37H,9-10,12-23,26-27H2,1-2H3,(H,48,58)(H,49,59)(H,50,63)(H,51,56,60)/b11-8-/t31-,32-,36-,37-/m1/s1 | Definition date: | 2023-03-28 | Last modified: | 2024-09-27 | Release date: | 2024-01-17 | Identifier: | (phenylmethyl) ~{N}-[(2~{R})-1-[[(~{Z},2~{S})-5-[4-[[1-[2-[(3~{R})-2,6-bis(oxidanylidene)piperidin-3-yl]-6-fluoranyl-1,3-bis(oxidanylidene)isoindol-5-yl]piperidin-4-yl]methyl]piperazin-1-yl]-5-oxidanylidene-1-[(3~{R})-2-oxidanylidenepyrrolidin-3-yl]pent-3-en-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate |
|
 | NME | Name: | METHYLAMINE | Formula: | C H5 N | SMILES: | NC | InChi: | InChI=1S/CH5N/c1-2/h2H2,1H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | methanamine |
|
 | L7L | Name: | (3~{S})-1-[3,5-bis(chloranyl)-4-oxidanyl-phenyl]carbonyl-~{N}-[2-[2-(dimethylamino)ethyldisulfanyl]ethyl]piperidine-3-carboxamide | Formula: | C19 H27 Cl2 N3 O3 S2 | SMILES: | CN(C)CCSSCCNC(=O)[CH]1CCCN(C1)C(=O)c2cc(Cl)c(O)c(Cl)c2 | InChi: | InChI=1S/C19H27Cl2N3O3S2/c1-23(2)7-9-29-28-8-5-22-18(26)13-4-3-6-24(12-13)19(27)14-10-15(20)17(25)16(21)11-14/h10-11,13,25H,3-9,12H2,1-2H3,(H,22,26)/t13-/m0/s1 | Definition date: | 2022-06-20 | Last modified: | 2024-09-27 | Release date: | 2023-04-26 | Identifier: | (3~{S})-1-[3,5-bis(chloranyl)-4-oxidanyl-phenyl]carbonyl-~{N}-[2-[2-(dimethylamino)ethyldisulfanyl]ethyl]piperidine-3-carboxamide |
|
 | QIP | Name: | 2-[(2~{S})-2-(3-methylsulfanylpropanimidoyl)-2-oxidanyl-4-oxidanylidene-imidazolidin-1-yl]-2-oxidanylidene-ethanamide | Formula: | C9 H14 N4 O4 S | SMILES: | CSCCC(=N)[C]1(O)NC(=O)CN1C(=O)C(N)=O | InChi: | InChI=1S/C9H14N4O4S/c1-18-3-2-5(10)9(17)12-6(14)4-13(9)8(16)7(11)15/h10,17H,2-4H2,1H3,(H2,11,15)(H,12,14)/b10-5-/t9-/m0/s1 | Synonyms: | CHROMOPHORE (MET-TYR-GLY) | Definition date: | 2022-11-01 | Last modified: | 2024-09-27 | Release date: | 2023-04-05 | Identifier: | 2-[(2~{S})-2-(3-methylsulfanylpropanimidoyl)-2-oxidanyl-4-oxidanylidene-imidazolidin-1-yl]-2-oxidanylidene-ethanamide |
|
 | VQR | Name: | methyl (4~{S})-4-[[(2~{S})-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]pentanoate | Formula: | C24 H35 N3 O6 | SMILES: | COC(=O)CC[CH](C[CH]1CCNC1=O)NC(=O)[CH](CC(C)C)NC(=O)OCc2ccccc2 | InChi: | InChI=1S/C24H35N3O6/c1-16(2)13-20(27-24(31)33-15-17-7-5-4-6-8-17)23(30)26-19(9-10-21(28)32-3)14-18-11-12-25-22(18)29/h4-8,16,18-20H,9-15H2,1-3H3,(H,25,29)(H,26,30)(H,27,31)/t18-,19-,20-/m0/s1 | Definition date: | 2023-03-28 | Last modified: | 2024-09-27 | Release date: | 2024-01-17 | Identifier: | methyl (4~{S})-4-[[(2~{S})-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]pentanoate |
|
 | NMI | Name: | 3-(1-methyl-1H-indol-3-yl)propanoic acid | Formula: | C12 H13 N O2 | SMILES: | O=C(O)CCc2c1ccccc1n(c2)C | InChi: | InChI=1S/C12H13NO2/c1-13-8-9(6-7-12(14)15)10-4-2-3-5-11(10)13/h2-5,8H,6-7H2,1H3,(H,14,15) | Definition date: | 2014-04-07 | Last modified: | 2024-09-27 | Release date: | 2014-06-18 | Identifier: | 3-(1-methyl-1H-indol-3-yl)propanoic acid |
|
 | 4CY | Name: | nitrilo-L-methionine | Formula: | C5 H8 N2 O2 S | SMILES: | N#CSCCC(C(=O)O)N | InChi: | InChI=1S/C5H8N2O2S/c6-3-10-2-1-4(7)5(8)9/h4H,1-2,7H2,(H,8,9)/t4-/m0/s1 | Definition date: | 2010-09-07 | Last modified: | 2024-09-27 | Identifier: | nitrilo-L-methionine |
|
 | O1Y | Name: | N-{3-[(6-{[(2,6-dichloro-3,5-dimethoxyphenyl)carbamoyl](methyl)amino}pyrimidin-4-yl)amino]-1-(2-hydroxyethyl)-1H-pyrazol-4-yl}prop-2-enamide | Formula: | C22 H24 Cl2 N8 O5 | SMILES: | c3(c(c(NC(N(c2cc(Nc1c(NC(/C=C)=O)cn(CCO)n1)ncn2)C)=O)c(Cl)c(c3)OC)Cl)OC | InChi: | InChI=1S/C22H24Cl2N8O5/c1-5-17(34)27-12-10-32(6-7-33)30-21(12)28-15-9-16(26-11-25-15)31(2)22(35)29-20-18(23)13(36-3)8-14(37-4)19(20)24/h5,8-11,33H,1,6-7H2,2-4H3,(H,27,34)(H,29,35)(H,25,26,28,30) | Definition date: | 2019-06-04 | Last modified: | 2024-09-27 | Release date: | 2019-06-19 | Identifier: | N-{3-[(6-{[(2,6-dichloro-3,5-dimethoxyphenyl)carbamoyl](methyl)amino}pyrimidin-4-yl)amino]-1-(2-hydroxyethyl)-1H-pyrazol-4-yl}prop-2-enamide |
|
 | UWH | Name: | 4-[4-(2-methoxyethyl)piperazin-1-yl]sulfonylbenzaldehyde | Formula: | C14 H20 N2 O4 S | SMILES: | COCCN1CCN(CC1)[S](=O)(=O)c2ccc(C=O)cc2 | InChi: | InChI=1S/C14H20N2O4S/c1-20-11-10-15-6-8-16(9-7-15)21(18,19)14-4-2-13(12-17)3-5-14/h2-5,12H,6-11H2,1H3 | Definition date: | 2021-03-23 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-[4-(2-methoxyethyl)piperazin-1-yl]sulfonylbenzaldehyde |
|
 | SXA | Name: | THIOACETIC ACID S-{2-[3-(2-HYDROXY-3,3-DIMETHYL-4-PHOSPHONOOXY-BUTYRYLAMINO)-PROPIONYLAMINO]-ETHYL} ESTER | Formula: | C13 H25 N2 O8 P S | SMILES: | O=C(SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)O)C | InChi: | InChI=1S/C13H25N2O8PS/c1-9(16)25-7-6-14-10(17)4-5-15-12(19)11(18)13(2,3)8-23-24(20,21)22/h11,18H,4-8H2,1-3H3,(H,14,17)(H,15,19)(H2,20,21,22)/t11-/m1/s1 | Definition date: | 2009-03-17 | Last modified: | 2024-09-27 | Identifier: | S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] ethanethioate |
|
 | X1B | Name: | {(4Z)-2-[(1S)-1-amino-2-(1-methyl-1H-imidazol-5-yl)ethyl]-4-[(4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetaldehyde | Formula: | C18 H19 N5 O4 | SMILES: | O=C1C(/N=C(C(N)Cc2cncn2C)N1CC(O)=O)=C/c1ccc(O)cc1 | InChi: | InChI=1S/C18H19N5O4/c1-22-10-20-8-12(22)7-14(19)17-21-15(18(27)23(17)9-16(25)26)6-11-2-4-13(24)5-3-11/h2-6,8,10,14,24H,7,9,19H2,1H3,(H,25,26)/b15-6-/t14-/m0/s1 | Synonyms: | CHROMOPHORE (N1-METHYLATED HIS-TYR-GLY) | Definition date: | 2023-10-18 | Last modified: | 2024-09-27 | Release date: | 2023-11-29 | Identifier: | {(4Z)-2-[(1S)-1-amino-2-(1-methyl-1H-imidazol-5-yl)ethyl]-4-[(4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | N8L | Name: | 1-[(2~{S})-2-(5-methyl-3-pyridin-4-yl-1~{H}-pyrazol-4-yl)pyrrolidin-1-yl]propan-1-one | Formula: | C16 H20 N4 O | SMILES: | CCC(=O)N1CCC[CH]1c2c(C)[nH]nc2c3ccncc3 | InChi: | InChI=1S/C16H20N4O/c1-3-14(21)20-10-4-5-13(20)15-11(2)18-19-16(15)12-6-8-17-9-7-12/h6-9,13H,3-5,10H2,1-2H3,(H,18,19)/t13-/m0/s1 | Definition date: | 2022-08-12 | Last modified: | 2024-09-27 | Release date: | 2022-09-28 | Identifier: | 1-[(2~{S})-2-(5-methyl-3-pyridin-4-yl-1~{H}-pyrazol-4-yl)pyrrolidin-1-yl]propan-1-one |
|
 | SXC | Name: | bromo(4-{3-[(R)-ethoxy(4-nitrophenoxy)phosphoryl]propyl}-2,6-bis[(methylsulfanyl-kappaS)methyl]phenyl-kappaC~1~)palladium(2+) | Formula: | C21 H27 Br N O5 P Pd S2 | SMILES: | [O-][N+](=O)c4ccc(OP(=O)(OCC)CCCc1cc2c3c(c1)C[S+](C)[Pd]3(Br)[S+](C2)C)cc4 | InChi: | InChI=1S/C21H27NO5PS2.BrH.Pd/c1-4-26-28(25,27-21-9-7-20(8-10-21)22(23)24)11-5-6-17-12-18(15-29-2)14-19(13-17)16-30-3 | Synonyms: | ethyl 4-nitrophenyl P-[3-(4-(bromopallado)-1,3-bis[(methylthio)methyl]-phenyl)propyl]phosphonate | Definition date: | 2008-10-08 | Last modified: | 2024-09-27 | Identifier: | bromo(4-{3-[(R)-ethoxy(4-nitrophenoxy)phosphoryl]propyl}-2,6-bis[(methylsulfanyl-kappaS)methyl]phenyl-kappaC~1~)palladium(2+) |
|
 | NMK | Name: | N-methyl Lysine | Formula: | C7 H17 N2 O2 | SMILES: | CN[CH](CCCC[NH3+])C(O)=O | InChi: | InChI=1S/C7H16N2O2/c1-9-6(7(10)11)4-2-3-5-8/h6,9H,2-5,8H2,1H3,(H,10,11)/p+1/t6-/m0/s1 | Definition date: | 2018-10-10 | Last modified: | 2024-09-27 | Release date: | 2019-01-16 | Identifier: | [(5~{S})-5-(methylamino)-6-oxidanyl-6-oxidanylidene-hexyl]azanium |
|
 | U5G | Name: | boceprevir (bound form) | Formula: | C27 H47 N5 O5 | SMILES: | C(=O)(NC(C)(C)C)NC(C(C)(C)C)C(N1CC3C(C1C(=O)NC(CC2CCC2)C(O)C(=O)N)C3(C)C)=O | InChi: | InChI=1S/C27H47N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-20,33H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16-,17-,18-,19+,20+/m0/s1 | Synonyms: | (1R,2S,5S)-N-[(2S,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl]-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | Definition date: | 2020-04-23 | Last modified: | 2024-09-27 | Release date: | 2020-05-06 | Identifier: | (1R,2S,5S)-N-[(2S,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl]-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
 | SXD | Name: | N-{2-[(3,5-dioxohexyl)sulfanyl]ethyl}-N~3~-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alaninamide | Formula: | C17 H31 N2 O9 P S | SMILES: | O=C(NCCSCCC(=O)CC(=O)C)CCNC(=O)C(O)C(C)(C)COP(=O)(O)O | InChi: | InChI=1S/C17H31N2O9PS/c1-12(20)10-13(21)5-8-30-9-7-18-14(22)4-6-19-16(24)15(23)17(2,3)11-28-29(25,26)27/h15,23H,4-11H2,1-3H3,(H,18,22)(H,19,24)(H2,25,26,27)/t15-/m1/s1 | Definition date: | 2009-04-02 | Last modified: | 2024-09-27 | Identifier: | N-{2-[(3,5-dioxohexyl)sulfanyl]ethyl}-N~3~-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alaninamide |
|
 | NML | Name: | N-METHYLACETAMIDE | Formula: | C3 H7 N O | SMILES: | O=C(NC)C | InChi: | InChI=1S/C3H7NO/c1-3(5)4-2/h1-2H3,(H,4,5) | Definition date: | 2006-10-27 | Last modified: | 2024-09-27 | Identifier: | N-methylacetamide |
|
 | XT8 | Name: | (2R,4S)-2-[(1R)-1-{[(2R)-2-carboxy-2-(thiophen-3-yl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | Formula: | C15 H18 N2 O6 S2 | SMILES: | C(=O)C(NC(C(c1cscc1)C(O)=O)=O)C2SC(C(C(O)=O)N2)(C)C | InChi: | InChI=1S/C15H18N2O6S2/c1-15(2)10(14(22)23)17-12(25-15)8(5-18)16-11(19)9(13(20)21)7-3-4-24-6-7/h3-6,8-10,12,17H,1-2H3,(H,16,19)(H,20,21)(H,22,23)/t8-,9-,10+,12-/m1/s1 | Synonyms: | ticarcillin | Definition date: | 2019-10-15 | Last modified: | 2024-09-27 | Release date: | 2019-10-30 | Identifier: | (2R,4S)-2-[(1R)-1-{[(2R)-2-carboxy-2-(thiophen-3-yl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
 | NMM | Name: | (2S)-2-amino-5-[(N-methylcarbamimidoyl)amino]pentanoic acid | Formula: | C7 H16 N4 O2 | SMILES: | O=C(O)C(N)CCCNC(=[N@H])NC | InChi: | InChI=1S/C7H16N4O2/c1-10-7(9)11-4-2-3-5(8)6(12)13/h5H,2-4,8H2,1H3,(H,12,13)(H3,9,10,11)/t5-/m0/s1 | Synonyms: | L-NMMA | Definition date: | 2005-12-28 | Last modified: | 2024-09-27 | Identifier: | N~5~-(N-methylcarbamimidoyl)-L-ornithine |
|
 | UWK | Name: | 4-[(3~{R})-3-methoxypiperidin-1-yl]sulfonylbenzaldehyde | Formula: | C13 H17 N O4 S | SMILES: | CO[CH]1CCCN(C1)[S](=O)(=O)c2ccc(C=O)cc2 | InChi: | InChI=1S/C13H17NO4S/c1-18-12-3-2-8-14(9-12)19(16,17)13-6-4-11(10-15)5-7-13/h4-7,10,12H,2-3,8-9H2,1H3/t12-/m1/s1 | Definition date: | 2021-03-24 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-[(3~{R})-3-methoxypiperidin-1-yl]sulfonylbenzaldehyde |
|
 | SXE | Name: | O-{(S)-ETHOXY[(1-METHYLETHYL)AMINO]PHOSPHORYL}-L-SERINE | Formula: | C8 H19 N2 O5 P | SMILES: | O=P(OCC)(OCC(N)C(=O)O)NC(C)C | InChi: | InChI=1S/C8H19N2O5P/c1-4-14-16(13,10-6(2)3)15-5-7(9)8(11)12/h6-7H,4-5,9H2,1-3H3,(H,10,13)(H,11,12)/t7-,16-/m0/s1 | Definition date: | 2007-02-13 | Last modified: | 2024-09-27 | Identifier: | O-{(S)-ethoxy[(1-methylethyl)amino]phosphoryl}-L-serine |
|